ABCL – AbCellera Biologics Inc.
Name : AbCellera Biologics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
24.34
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
0.05
EPS Last/This Y
-0.11
EPS This/Next Y
0.15
Price
3.7
Target Price
10.2
Analyst Recom
1.29
Performance Q
-20.99
Relative Volume
0.83
Beta
0.77
Ticker: ABCL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | ABCL | 5.86 | 0.09 | 0.21 | 90328 |
| 2025-10-21 | ABCL | 5.57 | 0.10 | 0.34 | 92578 |
| 2025-10-22 | ABCL | 5.47 | 0.10 | 2.12 | 93710 |
| 2025-10-23 | ABCL | 5.71 | 0.14 | 0.08 | 96682 |
| 2025-10-24 | ABCL | 5.65 | 0.14 | 0.13 | 97132 |
| 2025-10-27 | ABCL | 5.76 | 0.14 | 0.11 | 97398 |
| 2025-10-28 | ABCL | 5.62 | 0.14 | 0.11 | 97578 |
| 2025-10-29 | ABCL | 5.61 | 0.14 | 0.07 | 97681 |
| 2025-10-30 | ABCL | 5.36 | 0.14 | 0.22 | 97562 |
| 2025-10-31 | ABCL | 5.54 | 0.14 | 0.14 | 97557 |
| 2025-11-03 | ABCL | 5.36 | 0.13 | 0.52 | 98321 |
| 2025-11-04 | ABCL | 4.86 | 0.14 | 0.45 | 98942 |
| 2025-11-05 | ABCL | 4.68 | 0.16 | 0.44 | 100391 |
| 2025-11-06 | ABCL | 4.51 | 0.16 | 0.94 | 101513 |
| 2025-11-07 | ABCL | 3.9 | 0.19 | 0.24 | 104072 |
| 2025-11-10 | ABCL | 4.03 | 0.19 | 0.01 | 107009 |
| 2025-11-11 | ABCL | 4 | 0.17 | 0.10 | 119268 |
| 2025-11-12 | ABCL | 3.95 | 0.17 | 3.29 | 118915 |
| 2025-11-13 | ABCL | 3.61 | 0.17 | 0.16 | 118541 |
| 2025-11-14 | ABCL | 3.7 | 0.17 | 0.35 | 117803 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | ABCL | 5.86 | 4.7 | - | -0.60 |
| 2025-10-21 | ABCL | 5.57 | 4.7 | - | -0.60 |
| 2025-10-22 | ABCL | 5.47 | 4.7 | - | -0.60 |
| 2025-10-23 | ABCL | 5.71 | 4.7 | - | -0.60 |
| 2025-10-24 | ABCL | 5.65 | 4.7 | - | -0.60 |
| 2025-10-27 | ABCL | 5.77 | 4.7 | - | -0.60 |
| 2025-10-28 | ABCL | 5.63 | 4.7 | - | -0.60 |
| 2025-10-29 | ABCL | 5.62 | 4.7 | - | -0.60 |
| 2025-10-30 | ABCL | 5.36 | 4.7 | - | -0.60 |
| 2025-10-31 | ABCL | 5.55 | 4.7 | - | -0.60 |
| 2025-11-03 | ABCL | 5.36 | 4.7 | - | -0.60 |
| 2025-11-04 | ABCL | 4.87 | 4.7 | - | -0.60 |
| 2025-11-05 | ABCL | 4.68 | 4.7 | - | -0.60 |
| 2025-11-06 | ABCL | 4.52 | 4.7 | - | -0.60 |
| 2025-11-07 | ABCL | 3.91 | 4.7 | - | -0.60 |
| 2025-11-10 | ABCL | 4.03 | 4.7 | - | -0.60 |
| 2025-11-11 | ABCL | 4.01 | 4.7 | - | -0.66 |
| 2025-11-12 | ABCL | 3.95 | 4.7 | - | -0.66 |
| 2025-11-13 | ABCL | 3.60 | 4.7 | - | -0.66 |
| 2025-11-14 | ABCL | 3.70 | -83.3 | - | -0.66 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | ABCL | 0.00 | -9.96 | 20.47 |
| 2025-10-21 | ABCL | 0.00 | -9.96 | 20.47 |
| 2025-10-22 | ABCL | 0.00 | -9.96 | 20.47 |
| 2025-10-23 | ABCL | 0.00 | -9.96 | 20.47 |
| 2025-10-24 | ABCL | 0.00 | -9.96 | 20.47 |
| 2025-10-27 | ABCL | 0.00 | -10.31 | 23.60 |
| 2025-10-28 | ABCL | 0.00 | -10.31 | 23.60 |
| 2025-10-29 | ABCL | 0.00 | -10.31 | 23.60 |
| 2025-10-30 | ABCL | 0.00 | -10.31 | 23.60 |
| 2025-10-31 | ABCL | 0.00 | -10.31 | 23.60 |
| 2025-11-03 | ABCL | 0.00 | -9.88 | 23.60 |
| 2025-11-04 | ABCL | 0.00 | -9.88 | 23.60 |
| 2025-11-05 | ABCL | 0.00 | -9.88 | 23.60 |
| 2025-11-06 | ABCL | 0.00 | -9.88 | 23.60 |
| 2025-11-07 | ABCL | 0.00 | -9.88 | 23.60 |
| 2025-11-10 | ABCL | 0.00 | -9.33 | 23.56 |
| 2025-11-11 | ABCL | 0.00 | -9.33 | 23.56 |
| 2025-11-12 | ABCL | 0.00 | -9.33 | 24.43 |
| 2025-11-13 | ABCL | 0.00 | -9.33 | 24.34 |
| 2025-11-14 | ABCL | 0.00 | -9.33 | 24.34 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL
589 360 ]
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.22
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
Institutional Transactions
-9.33
Beta
0.77
Average Sales Estimate Current Quarter
5
Average Sales Estimate Next Quarter
13
Fair Value
Quality Score
20
Growth Score
31
Sentiment Score
31
Actual DrawDown %
94.9
Max Drawdown 5-Year %
Target Price
10.2
P/E
Forward P/E
PEG
P/S
31.27
P/B
1.14
P/Free Cash Flow
EPS
-0.58
Average EPS Est. Cur. Y
-0.66
EPS Next Y. (Est.)
-0.51
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-486.01
Relative Volume
0.83
Return on Equity vs Sector %
-44.7
Return on Equity vs Industry %
-29.9
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.06
EBIT Estimation
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL
589 450 ]
AbCellera Biologics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL
premarket after hours
ticker ABCL
fair value insiders trading